Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,843 | 7,227 | 3,793 | 749 | 3,103 |
| Inventories | 727 | 590 | 323 | 341 | 175 |
| Other current assets | 6 | 0 | 101 | 122 | 122 |
| TOTAL | $18,351 | $8,208 | $4,780 | $2,275 | $3,773 |
| Non-Current Assets | |||||
| PPE Net | 226 | 212 | 226 | 215 | 237 |
| Other Non-Current Assets | 322 | 345 | 356 | 373 | 389 |
| TOTAL | $547 | $557 | $582 | $587 | $626 |
| Total Assets | $18,899 | $8,765 | $5,361 | $2,863 | $4,399 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 687 | 910 | 1,325 | 1,169 | 1,444 |
| TOTAL | $766 | $987 | $1,399 | $1,240 | $1,551 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29 | 337 | 337 | 337 | N/A |
| Other Non-Current Liabilities | 252 | 272 | 291 | 308 | 326 |
| TOTAL | $281 | $609 | $628 | $646 | $326 |
| Total Liabilities | $1,047 | $1,596 | $2,026 | $1,886 | $1,877 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | 0 |
| Common Shares | 4 | 3 | 3 | 2 | 1 |
| Retained earnings | -59,729 | -57,339 | -55,088 | -51,434 | -48,540 |
| Other shareholders' equity | 116 | 11 | 139 | 182 | 79 |
| TOTAL | $17,852 | $7,169 | $3,335 | $977 | $2,522 |
| Total Liabilities And Equity | $18,899 | $8,765 | $5,361 | $2,863 | $4,399 |